Recent news on Xeloda Capecitabine

Many Health Plans that Cover Tykerb Are Using Prior Authorization  -  May 15, 2007
Atlantic Information Services, Inc.,The FDA on March 13 approved Tykerb in combination with Xeloda (capecitabine) for the treatment of HER2-(human epidermal growth factor receptor 2-) positive

Roche updates on flu manufacturing; expands US unit  -  Apr 26, 2007
OutSourcing-Pharma.com,It has contributed to the development of manufacturing protocols for a number of Roche's leading brands, including cancer drug Xeloda (capecitabine),

Antisense—down, but not out  -  Apr 30, 2007
Nature.com (subscription),...is combined with the oral chemotherapy drug Xeloda (capecitabine; Roche Laboratories, Nutley, NJ, USA) in phase 2 trials for kidney cancer.

Roche updates on flu manufacturing; expands US unit  -  26 Apr 2007
In-PharmaTechnologist.com,It has contributed to the development of manufacturing protocols for a number of Roche's leading brands, including cancer drug Xeloda (capecitabine),

The High Cost of New Cancer Therapies Has Made Them Targets for ...  -  Apr 20, 2007
Genetic Engineering News (press release),...or metastatic breast cancer in combination with Xeloda (capecitabine) in women who have received prior therapy, including Herceptin (trastuzumab).

Roche applies for drug license extensions  -  Apr 17, 2007
newratings.comThe application is for allowing the use of Xeloda (capecitabine) and Xelox (oxaliplatin), with or without Avastin (bevacizumab), for the treatment of

Research and Markets: Ixabepilone is Predicted to Reach the Market ...  -  Apr 18, 2007
PharmaLive.com (press release),...to reach the market in late 2007 for the second-line treatment of patients with metastatic breast cancer in combination with Xeloda (capecitabine).

GSK gets FDA nod for cancer drug  -  Apr 4, 2007
Express Pharma,GlaxoSmithKline received an approval for Tykerb (lapatinib), in combination with Xeloda (capecitabine), for the treatment of patients with advanced or

Roche Submits Application to the FDA for use of XELOX (Xeloda(R ...  -  Apr 5, 2007
Drug Newswire (press release),XELOX is an abbreviation for a type of combination chemotherapy used to treat colorectal cancer; it contains XELODA (capecitabine) plus oxaliplatin.

Roche's Xeloda approved in EU for advanced stomach cancer  -  Mar 30, 2007
Pharma Times (subscription),The Basel-based firm said that the European Commission has approved Xeloda (capecitabine) treatment in combination with platinum-based chemotherapy,

Amgen reschedules plans for Ireland but commitment is still strong  -  Apr 5, 2007
Pharma Times (subscription),...which has just been approved by the US Food and Drug Administration for advanced breast cancer, in combination with Roche's Xeloda (capecitabine).

GSK files in Japan for Tykerb and in Europe for Globorix  -  Apr 2, 2007
Pharma Times (subscription),The drugmaker is seeking the green light for Tykerb (lapatinib) as a monotherapy and in combination with Roche's chemotherapy agent Xeloda (capecitabine),

GlaxoSmithKline to create 150 jobs in Cork over next five years  -  Mar 29, 2007
FinFacts Ireland,...in combination with Xeloda (capecitabine), for the treatment of patients with advanced or metastatic breast cancer whose tumours overexpress HER2 and

Avastin approved for metastatic breast cancer in EU  -  Mar 29, 2007
Pharma Times (subscription),...in the first-line treatment of the disease in combination with docetaxel and other commonly used chemotherapies including its own Xeloda (capecitabine).

Roche Submits Application to the FDA for use of XELOX (Xeloda(R ...  -  27 Mar 2007
PR Newswire (press release),About XELOX XELOX is an abbreviation for a type of combination chemotherapy used to treat colorectal cancer; it contains XELODA (capecitabine) plus

FDA Approves Tykerb (lapatinib) in Combination With Xeloda ...  -  Mar 13, 2007
PharmaLive.com (press release),PHILADELPHIA, March 13, 2007 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc announced today that the United States Food and Drug Administration (FDA)

FDA approves Tykerb and Xeloda for the treatment of advanced or ...  -  Mar 13, 2007
HULIQ,FDA approves Tykerb (lapatinib) in combination with Xeloda (capecitabine) for the treatment of advanced or metastatic breast cancer in women who have

FDA Approves Tykerb And Xeloda To Treat Advanced Breast Cancer  -  Mar 13, 2007
All Headline NewsThe GlaxoSmithKline PLC drug, Tykerb (lapatinib) in combination with Xeloda (capecitabine) is to be taken once daily in pill form by women who have received

New Hope in the Fight Against Breast Cancer  -  Mar 24, 2007
Associated Content,The new pill is to be used in conjunction with Xeloda (capecitabine), a chemotherapy pill. While it is not known if the new pill will help women live longer

FDA approves GSK's Tykerb for advanced breast cancer  -  Mar 14, 2007
Pharma Times (subscription),Food and Drug Administration has granted marketing approval for Tykerb (lapatinib) in combination with Roche's chemotherapy agent Xeloda (capecitabine),

FDA approves Tykerb for advanced or metastatic breast cancer  -  Mar 15, 2007
Compliance Home,...in combination with Xeloda (capecitabine), for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress HER2 and who

Oral Cancer Drug Xeloda Receives Positive Opinion From The ...  -  Feb 26, 2007
Medical News Today (press release),Roche announced today that its innovative oral cancer drug Xeloda (capecitabine), in combination with platinum-based chemotherapy, has received a positive

GlaxoSmithKline: Tykerb set to boost oncology portfolio  -  Mar 15, 2007
Pharmaceutical Business Review...'Content The FDA has granted regulatory approval to GlaxoSmithKline's Tykerb (lapatinib) in combination with Roche's Xeloda (capecitabine) for the treatment

New Drug Approved for Breast Cancer  -  Mar 14, 2007
ACS News Center,Tykerb comes in pill form and must be used in combination with Xeloda (capecitabine), a chemotherapy pill. In a clinical trial of nearly 400 women,

FDA clears Glaxo pill for breast cancer  -  Mar 13, 2007
ReutersWASHINGTON (Reuters) - US health regulators have approved GlaxoSmithKline Plc's (GSK.L: Quote, Profile, Research) (GSK.N: Quote, Profile, Research) pill

US FDA clears Glaxo pill for breast cancer  -  Mar 13, 2007
Reuters.uk,WASHINGTON, March 13 (Reuters) - US health regulators have approved GlaxoSmithKline Plc's (GSK.L: Quote, Profile , Research) (GSK.

FDA clears Glaxo pill for breast cancer  -  Mar 13, 2007
KPLC-TV,WASHINGTON (Reuters) - US health regulators have approved GlaxoSmithKline Plc's (GSK.L) (GSK.N) pill Tykerb for patients with advanced breast cancer after

GSK's new breast cancer drug approved  -  Mar 16, 2007
DrugResearcher.com,Administration (FDA) to treat late stage cancers that have spread around the body, in combination with Roche's chemotherapy drug Xeloda (capecitabine).

GlaxoSmithKline: Tykerb looks for expansion in head and neck cancer  -  Feb 27, 2007
Pharmaceutical Business ReviewTykerb is currently in preregistration in the US and EU for use in combination with Roche's Xeloda (capecitabine) for the treatment of advanced or

Oral Cancer Drug Xeloda Receives Positive Opinion from the ...  -  Feb 23, 2007
PharmaLive.com (press release),23, 2007-Roche announced today that its innovative oral cancer drug Xeloda (capecitabine), in combination with platinum-based chemotherapy, has received a

EU panel backs Novartis' mock-up pandemic flu vaccine  -  Feb 23, 2007
MarketWatchXeloda (capecitabine), from Roche Registration Ltd, to extend the indication to include first-line treatment of patients with advanced gastric cancer in

Roche Posts Outstanding Results for 2006  -  Feb 7, 2007
PharmaLive.com (press release),Xeloda (capecitabine) is an effective oral anticancer therapy that greatly simplifies treatment and also saves costs by reducing the need for hospital

Abraxane in Combination with Xeloda Effective Against Metastatic ...  -  Jan 3, 2007
Cancer Consultants (press release),Abraxane (albumin-bound paclitaxel) in combination with Xeloda (capecitabine) is effective in the treatment of metastatic breast cancer.

Xeloda(R) Combination Meets Primary Endpoint In International ...  -  Dec 24, 2006
Medical News Today (press release),XELOX is an abbreviation for a type of combination chemotherapy used to treat colorectal cancer; it contains Xeloda (capecitabine) plus oxaliplatin.

Tykerb Plus Chemotherapy Slows Advance of Metastatic Breast Cancer  -  Dec 28, 2006
MedPage Today,...advanced-stage breast cancer, the time to disease progression may be doubled by adding Tykerb (lapatinib) to Xeloda (capecitabine) chemotherapy,

Safe Practice Guidelines for Oral Chemotherapy Found Gravely Lacking  -  Jan 12, 2007
MedPage Today,The drugs included Xeloda (capecitabine), Cytoxan (cyclophosphamide), Iressa (gefitinib), Gleevec (imatinib), oral Rheumatrex (oral methotrexate),

Xeloda(R) Combination Meets Primary Endpoint In International ...  -  Dec 24, 2006
Medical News Today (press release),XELOX is an abbreviation for a type of combination chemotherapy used to treat colorectal cancer; it contains Xeloda (capecitabine) plus oxaliplatin.

Xeloda Meets Primary Endpoint in Multinational Phase III Advanced ...  -  Dec 10, 2006
Earthtimes.orgAn abbreviation for a type of combination chemotherapy used to treatcolorectal cancer; it contains Xeloda (capecitabine) plus oxaliplatin.

SABCS: Abraxane Combination Therapy Effective for Metastatic ...  -  Dec 18, 2006
MedPage Today,...the nanoparticle albumin-bound form of paclitaxel, appears effective against metastatic breast cancer in combination with Xeloda (capecitabine),

GPC Biotech Reports Financial Results for Third Quarter and First ...  09 Nov 2006
Tarceva® (erlotinib) is a registered trademark of OSI Pharmaceuticals, Inc. Xeloda® (capecitabine) is a registered trademark of Hoffmann-La Roche AG. ... -Yahoo! News (press release) Danish Patients with Colorectal Cancer Prefer 5-FU/Leucovorin to ...  Oct 26, 2006
...reported that patients with colorectal cancer preferred to be treated with intravenous fluorouracil (5-FU)/leucovorin rather than oral Xeloda® (capecitabine). ... -Cancer Consultants (press release), Addition of Xeloda® to Herceptin® and Taxotere® Delays Cancer ...  Oct 12, 2006
Researchers involved in the CHAT study have reported that the addition of oral Xeloda® (capecitabine) to Herceptin® (trastuzumab) and Taxotere® (docetaxel ... -Cancer Consultants (press release), XELOX as Effective as FOLFOX in Advanced Colorectal Cancer  Oct 11, 2006
Xeloda® (capecitabine) is a chemotherapy agent that can be taken orally. It produces the same anticancer effects as 5-fluorouracil. ... -Cancer Consultants (press release), New Breast Cancer Drug Tykerb From Glaxo May Be Within Months In ...  Oct 8, 2006
United States Food and Drug Administration (FDA) for approval to market Tykerb® (lapatinib ditosylate), in combination with Xeloda® (capecitabine), for the ... -eMaxHealth.com, Avastin® Improves PFS Following XELOX or FOLFOX for Colorectal ...  Oct 13, 2006
...cancer. XELOX (oral Xeloda®, capecitabine) plus Eloxatin is as effective as FOLFOX-4 but more convenient to administer. Avastin ... -Cancer Consultants (press release), Xeloda® Plus Taxol® Effective as Initial Therapy in Metastatic ...  Sep 22, 2006
Researchers affiliated with US Oncology Network and the University of North Carolina have reported that the combination of Xeloda® (capecitabine) and Taxol ... -Cancer Consultants

Xeloda® plus Taxol® Effective as Initial Therapy in Metastatic ...  Sep 20, 2006
According to an article recently published in the Journal of Clinical Oncology, the chemotherapy combination including Xeloda® (capecitabine) and Taxol® is ... -Cancer Consultants

New Breast Cancer Drug Seeks FDA Approval  Sep 18, 2006
...or Xeloda alone. In this pivotal trial, the combination of TYKERB and Xeloda (capecitabine), versus Xeloda alone. The new breast ... -Toronto Daily News

GlaxoSmithKline: Tykerb filed for approval  Sep 20, 2006
...been granted fast track status, GSK's marketing application seeks approval of Tykerb (lapatinib) in combination with Roche's Xeloda (capecitabine) for the ... -Pharmaceutical Business Review

Xeloda®/Temodar® Effective for Breast Cancer Spread to Brain  Sep 6, 2006
According to an article recently published in the journal Cancer, the chemotherapy combination including Xeloda® (capecitabine) and Temodar® (temozolomide ... -Cancer Consultants

Market Report -- In Play (GSK)  Sep 18, 2006
...the submission of a New Drug Application to the FDA for approval to market Tykerb (lapatinib ditosylate), in combination with Xeloda (capecitabine), for the ... -MSN Money

GlaxoSmithKline Seeks US Approval for Tykerb (lapatinib Ditosylate ...  Sep 18, 2006
United States Food and Drug Administration (FDA) for approval to market Tykerb ® (lapatinib ditosylate), in combination with Xeloda® (capecitabine), for the ... -PharmaLive.com

Glaxo Seeks Approval for Tykerb for the Treatment of Advanced ...  Sep 18, 2006
United States Food and Drug Administration (FDA) for approval to market Tykerb® (lapatinib ditosylate), in combination with Xeloda® (capecitabine), for the ... -eMaxHealth.com

GSK Submits Tykerb for Market Approval  Sep 18, 2006
FDA), for approval to market. Tykerb® (lapatinib ditosylate), in combination with Xeloda® (capecitabine). The new compound is ... -International Business Times

Glaxo Submits Application For Tykerb In Breast Cancer  Sep 18, 2006
Specifically, the London pharmaceutical firm applied to market its compound in combination with Xeloda (capecitabine, F. Hoffmann-La Roche Ltd.) for advanced ... -Therapeutics Daily (subscription)

Xeloda Meets Primary Endpoint in Multinational Phase III Advanced ...  -  Dec 11, 2006
PR Newswire Brasil (liberação de imprensa),About XELOX An abbreviation for a type of combination chemotherapy used to treat colorectal cancer; it contains Xeloda (capecitabine) plus oxaliplatin.

GPC Biotech Reports Financial Results for Second Quarter and First ...  Aug 7, 2006
...with advanced non-small cell lung cancer * Phase 1/2 study evaluating satraplatin in combination with radiation therapy and Xeloda® (capecitabine) in patients ... -Yahoo! News

Large International Phase III Trial in Metastatic Colorectal ...  Jul 30, 2006
About XELOX XELOX is an abbreviation for a type of combination chemotherapy used to treat colorectal cancer; it contains Xeloda (capecitabine) plus oxaliplatin ... -PR Newswire

AVASTIN AND XELODA MEET PRIMARY ENDPOINTS IN LARGE PHASE III FIRST ...  Jul 30, 2006
An abbreviation for a type of combination chemotherapy used to treat colorectal cancer; it contains Xeloda (capecitabine) plus oxaliplatin. ... -ITNews

New Study Validates Roche's Xelox in Colorectal Cancer  Aug 3, 2006
Swiss drug major Roche has reported positive data on a chemotherapy regimen containing its drug Xeloda (capecitabine). The large ... -Therapeutics Daily (subscription)

Xeloda Filed in Europe for Treatment of Advanced Stomach Cancer  Jul 21, 2006
The European Medicines Agency informed Roche today that the filing for a new indication in Europe for the oral cancer drug Xeloda (capecitabine) in combination ... -PharmaLive.com

Abraxis BioScience: A SPARC for Explosive Growth? (ABBI)  Jul 19, 2006
...first-line metastatic breast cancer, in combination with Herceptin in HER 2 positive patients; in combination with Roche Labs’ Xeloda (Capecitabine) or with ... -Seeking Alpha

Xeloda® Approved for Adjuvant Treatment of Stage III Colon Cancer  Jun 30, 2006
The Food and Drug Administration (FDA) recently approved the oral chemotherapy agent Xeloda (capecitabine) for post-surgery treatment in patients with stage ... -Cancer Consultants



Spectrum Pharma Says Partner GPC Biotech Begins Phase 1 Trial ...  17 May 2006
GPC Biotech AG, has initiated a Phase 1 study evaluating the company's lead drug candidate, satraplatin, in combination with Xeloda* (capecitabine) in patients ... - Trading Markets

Sirtex begins liver cancer combo trial  May 9, 2006
Xeloda (capecitabine), meanwhile, is the only FDA-approved oral chemotherapy for metastatic breast cancer, and adjuvant and metastatic colorectal cancer. ... - Pharmaceutical Business Review

European Study Suggests Xeloda® is Cost Effective Compared to 5 ...  May 2, 2006
Researchers from the UK have determined that Xeloda (capecitabine) is more economical to administer that 5-fluorouracil/leucovorin (5-FU/LV) for the treatment ... - Cancer Consultants

Sirtex Announces Clinical Trial Evaluating the Use of SIR-Spheres ...  May 8, 2006
...the launch of a clinical trial evaluating the use of SIR-Spheres(R) microspheres in combination with the oral chemotherapy Xeloda (capecitabine) for patients ... - Genetic Engineering News

Xeloda®, Eloxatin® and Tarceva® Effective for Previously ...  Apr 28, 2006
Researchers from the Dana Farber Cancer Center have reported that the combination of oral Xeloda (capecitabine), intravenous Eloxatin (oxaliplatin) and oral ... - Cancer Consultants

Xeloda®, Eloxatin®, and Tarceva® Effective for Previously ...  Apr 19, 2006
...to an article recently published in the Journal of Clinical Oncology, the treatment combination consisting of Xeloda® (capecitabine), Eloxatin® (oxaliplatin ... - Cancer Consultants

Oral chemotherapy option soon for cancer  Apr 17, 2006
New Delhi, April 17 (IANS) Swiss pharmaceutical major Roche's study investigating Xeloda (capecitabine) in the first-line treatment of advanced stomach cancer ... - DailyIndia.com

Oral chemotherapy option soon for cancer  Apr 17, 2006
New Delhi: Swiss pharmaceutical major Roche's study investigating Xeloda (capecitabine) in the first-line treatment of advanced stomach cancer has successfully ... - NewKerala.com

XELOX Is Well Tolerated First-Line Regimen for Elderly Patients ...  Apr 24, 2006
Researchers from Spain have reported that the combination of Xeloda® (capecitabine) and Eloxatin® (oxaliplatin) known as XELOX is a well tolerated regimen ... - Cancer Consultants

Camptosar® and Eloxatin® Safe and Effective for Initial ...  Apr 25, 2006
Eloxatin has been combined with 5FU and leucovorin with or without Camptosar®, with Tomudex® (Ralitrexed, and with Xeloda (capecitabine)). ... - Cancer Consultants

Intrathecal Herceptin® May Halt Cancer Progression Within the ...  Apr 24, 2006
...was surgically removed. She then received the chemotherapy agent Xeloda® (capecitabine) plus intravenous Herceptin. When her condition ... - Cancer Consultants





Health Canada Approves Xeloda (Capecitabine) for Adjuvant Therapy ...  Mar 28, 2006
...announced today that Health Canada has approved Xeloda (capecitabine), an innovative oral chemotherapy, for the adjuvant treatment of patients with stage III ... - DG News

Oral Chemotherapy Xeloda Shown to be Effective in Stomach Cancer  Apr 6, 2006
BASEL, Switzerland, April 6, 2006--Roche today announced that the first-ever phase III study investigating Xeloda (capecitabine) in the first-line treatment in ... - PharmaLive.com

Addition of Tykerb® to Xeloda® Slows Cancer Progression in ...  Apr 5, 2006
...published by GlaxoSmithKline, the addition of the investigative agent Tykerb® (lapatinib) to the chemotherapy agent Xeloda® (capecitabine) slows cancer ... - Cancer Consultants

Xeloda® Effective in Gastric Cancer  Apr 6, 2006
According to a press release by Roche, the chemotherapy agent Xeloda® (capecitabine) appears to be just as effective as 5-fluorouracil in the treatment of ... - Cancer Consultants

New drug for breast cancer boosts GSK  Apr 4, 2006
...analysis of 321 patients found “statistically significant results� from using the drug in combination with the chemotherapy treatment Xeloda (capecitabine ... - Times Online

GSK targets Tykerb for second half OK  Apr 4, 2006
The trial showed that Tykerb plus Sanofi-Aventis' Xeloda (capecitabine) was significantly better than Xeloda alone in improving time to disease progression in ... - Pharma Times (subscription)

Phase II Trial of Taxotere® and Xeloda® for Metastatic Gastric ...  Mar 30, 2006
...metastatic adenocarcinoma of the stomach or gastroesophageal junction with the chemotherapy drugs Taxotere® (docetaxel) and Xeloda® (capecitabine) reduced or ... - Cancer Consultants



Patients Prefer Xeloda® to 5-Flurouracil in Treatment of ...  Feb 15, 2006
According to an article recently published in the Annals of Oncology, patients with colorectal cancer prefer the chemotherapy agent Xeloda® (capecitabine) to 5 ... - Cancer Consultants,

Roche halts enrollment in Avastin trial  Feb 13, 2006
...was stopped as it emerged that more deaths had occurred in patients taking a combination of Avastin and Xelox (Roche's Xeloda [capecitabine] plus Sanofi-Aventis ... - Pharma Times (subscription),

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional